Tango Therapeutics TNGX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's common stock, shares, outstanding?
- Tango Therapeutics (TNGX) reported common stock, shares, outstanding of $144.16M in Q1 2026.
- How has Tango Therapeutics's common stock, shares, outstanding changed year-over-year?
- Tango Therapeutics's common stock, shares, outstanding increased by 33.4% year-over-year, from $108.11M to $144.16M.
- What is the long-term trend for Tango Therapeutics's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Tango Therapeutics's common stock, shares, outstanding has grown at a 27.5% compound annual growth rate (CAGR), from $40.37M to $135.94M.